Home Categories Biochemical Engineering ASP3026
A0779612

ASP3026 , ≥98% , 1097917-15-1

CAS NO.:1097917-15-1

Empirical Formula: C29H40N8O3S

Molecular Weight: 580.74

MDL number: MFCD21609265

EINECS: 200-258-5

Pack Size Price Stock Quantity
5MG RMB445.60 In Stock
25MG RMB1599.20 In Stock
100MG RMB3999.20 In Stock
others     Enquire
Update time: 2022-07-08

PRODUCT Properties

Boiling point: 794.3±70.0 °C(Predicted)
Density  1.276
storage temp.  Store at -20°C
solubility  insoluble in H2O; ≥14.53 mg/mL in DMSO; ≥4.9 mg/mL in EtOH with gentle warming and ultrasonic
form  solid
pka 8.14±0.42(Predicted)
color  White to off-white

Description and Uses

ASP3026 is an ATP-competitive, second-generation ALK inhibitor (IC50 = 3.5 nM) that also inhibits ROS (IC50 = 8.9 nM) and ACK (IC50 = 5.8 nM). It inhibits neuroblastoma-activating ALK mutants F1174L (IC50 = 10 nM) and R1275Q (IC50 = 5.4 nM) and demonstrates antitumor activity in xenograft mouse models. ASP3026 has been shown to overcome crizotinib resistance in non-small cell lung cancer, and is currently being evaluated in clinical trials of patients with ALK-positive solid tumors.

ASP3026 is a novel and selective anaplastic lymphoma kinase (ALK) inhibitor that shows potent anti-tumor activities. ASP3026 also shows potential efficacy for non-small cell lung cancer (NSCLC) and is expected to improve the therapeutic outcomes of patients with cancer with ALK abnormality. Potent ALK inhibitor.

Safety

Symbol(GHS) 
GHS07
Signal word  Warning

RELATED PRODUCTS